Forskningsområde

• Estimating exercise capacity to guide intervention studies in children and adults.
• Studying low-dose glucagon injections for hypoglycemia prevention and treatment.
• Examining different dietary approaches to maximize the benefits of diabetes technologies.
• Analyzing device behavior as predictors for optimal glucose control in type 1 and type 2 diabetes, children, and adults.
• Evaluating the impact of automated insulin pumps (AID) including vulnerable groups.
• Assessing additional benefits of AID beyond the glycemic control (sleep, inflammation, cognition).
• Evaluating and preventing skin issues related to technology use.
• Developing Stenopool, a device uploading program and decision support system.
• Investigating impact of glucometrics on risk of late complications.
• Developing and evaluating the effect of diabetes self-management education, new learning strategies and support and the use of diabetes technologies.
• Studying sleep in children and adults with type 1 diabetes.
• Testing continuous glucose monitoring (CGM) use at inpatient wards and intensive care units.
• Studying efficacy of automated insulin pens.
• Assessing efficacy of education film and of AID use in pregnancy.
• Evaluating efficacy of technology (CGM and AID) in type 2 diabetes.​​

​